Safety and Efficacy of NOM and OPFS Versus RO for dMMR/MSI-H or POLE-Mutated Gastrointestinal Cancers

NCT07642323 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Cancers
Gastrointestinal Cancers - Stomach
Gastrointestinal Cancers - Colorectal
Gastrointestinal Cancers - Anus

Interventions

OTHER: NOM/OPFS

Sponsor

Peking University Cancer Hospital & Institute